THTsuyoshi Hayashi

Tsuyoshi Hayashi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tsuyoshi Hayashi has a total of 150 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Early Detection of Pancreatic Adenocarcinoma Using Triple-phase contrast-enhanced Computed Tomography: A Case-control Study

    byĀ Tsuyoshi Hayashi, Yoshihisa Kodama, Yasuo Sakurai, Hajime Yamazaki, Yukiko Takigawa, Haruka Toyonaga, Tatsuya Ishii, Toshifumi Kin, Kuniyuki Takahashi, Akio Katanuma

    Objectives: To investigate the imaging findings of the triple-phase computed tomography (CT), which was performed prior to definitive diagnoses in patients with Pancreatic ductal adenocarcinoma (PDAC). Methods: The single-center, retrospective, case-control study included patients with PDAC who underwent triple-phase CT 3–36 months prior to definitive diagnosis (pre-diagnostic CT) between January 2007 and March 2018 in Teine Keijinkai hospital. Triple-phase CT in sex- and age-matched patients without PDAC appearance in a 4:1 ratio were selected as controls. Findings were detected from each of the five divided pancreatic sections on pre-diagnostic CT by radiologists’ reviews, and were analyzed by comparison with CT at the definitive diagnosis (diagnostic CT) to investigate risk ratios. Results: Pre-diagnostic CTs were investigated in 190 and 760 sections with 38 PDAC and 152 control patients. In the diagnostic CT, 50 PDAC-positive and 900 negative sections were detected, respectively. In pre-diagnostic CT review, some findings were shown in 17 (34.0%) and 18 (2.0%) sections among PDAC-positive and negative sections, respectively, and the total number of findings was 46 and 28 in PDAC-positive and negative sections, respectively. Finally, different attenuation of pancreatic parenchyma in each phase, MPD stenosis, and focal pancreatic parenchymal atrophy were significantly correlated with the risk of PDAC. Conclusions: While some findings may already appear on the pre-diagnostic CT in one-third of the PDAC-positive sections, an accurate and detailed review in triple-phase CT is indispensable to detect early PDAC in clinical practice.

  • Visibility of the biliary orifice after precut papillotomy: Comparison between white light imaging and texture and color enhancement imaging

    byĀ Haruka Toyonaga, Toshifumi Kin, Hajime Yamazaki, Ryo Ando, Kosuke Iwano, Risa Nakamura, Tatsuya Ishii, Tsuyoshi Hayashi, Kuniyuki Takahashi, Akio Katanuma

    Background: Precut papillotomy is performed in cases of difficult biliary cannulation, but identification of the biliary orifice is difficult. Texture and color enhancement imaging (TXI) can enhance the structure, color, and brightness. This study compared TXI and white light imaging (WLI) in visibility of biliary orifices.Methods: We retrospectively examined 20 patients who underwent bile duct cannulation using both WLI and TXI after precut papillotomy at our center between 2021 and 2022. On WLI and TXI images displayed in random order, bile duct orifice on precut‐incision surface of each image was independently evaluated by eight evaluators. Single‐indication accuracy rate of biliary orifices, visibility score rated on a 4‐grade scale, and color difference between the biliary orifice and the surrounding tissue were examined.Results: The single‐indication accuracy rate was higher in TXI compared to WLI (50.6% vs. 35.6%, odds ratio 2.26 [95% CI: 1.32–3.89], p = .003). The time to indicate the biliary orifice was comparable between TXI and WLI (median, 9.7 s [range, 2.6–43] vs. 10.9 s [1.5–64], p = .086). Furthermore, the visibility score was higher in TXI than in WLI (median, 3 [interquartile range, 2–3] vs. 2 [2, 3], p < .001), and the color difference between the biliary orifice and surrounding tissue in TXI was more pronounced than in WLI (median, 22.9 [range, 9.39–55.2] vs. 18.0 [6.48–43.0]; p < .001).Conclusions: TXI enhanced the color difference and visibility of the biliary orifice after precut and improved single‐indication accuracy rate, suggesting that it could be useful for biliary cannulation after precut papillotomy.


  • Endoscopic retrieval of the torn pancreatic stent by pushing out through the EUS‐PD fistula tract

    byĀ Kenta Yoshida, Haruka Toyonaga, Tsuyoshi Hayashi, Masayo Motoya, Toshifumi Kin, Kuniyuki Takahashi, Akio Katanuma

  • Open Access

    Gel immersion technique in interventional endoscopic ultrasound for pancreatobiliary lesions

    byĀ Haruka Toyonaga, Tsuyoshi Hayashi, Kazuki Hama, Toshifumi Kin, Masayo Motoya, Kuniyuki Takahashi, Akio Katanuma

    Interventional endoscopic ultrasound (iEUS), including EUS-guided tissue acquisition (EUS-TA) and biliary drainage (EUS-BD), plays a crucial role in the assessment and treatment of pancreaticobiliary lesions. Yet, iEUS presents challenges due to anatomical factors, posing a risk of serious complications. For observational pancreaticobiliary EUS, studies have shown that utilizing a high viscosity gel (Viscoclear; Otsuka Pharmaceutical, Tokushima, Japan) instead of water to fill the duodenal lumen yields clearer EUS images and effectively maintains the luminal dilatation for an extended period [1] [2] [3]. Recently, a handful of reports have explored the gel immersion technique within iEUS [4] [5]. Here, we evaluate the effectiveness and safety of the gel immersion method, particularly in EUS-TA and EUS-BD ([Video 1]). EUS-TA was carried out in instances of nonexposed-type ampullary tumors presenting with jaundice, where multiple endoscopic biopsies failed to confirm malignancy. Gel immersion facilitated clear imaging without the need to compress the papilla with the EUS tip or embedding it in the mucosal folds. This approach enabled successful tissue sampling and the detection of malignancy ([Fig. 1]). When conducting iEUS from the duodenal bulb with a convex-type EUS scope, there can be visibility issues for both the needle and the gastrointestinal wall due to air trapped within the duodenal bulb space. This increases the risk of a ā€œdouble punctureā€ involving the gastropyloric ring and the duodenal wall, attributed to the gap between the tip of the EUS probe and the instrument channel. Gel immersion mitigates these risks by displacing the air disrupting ultrasound transmission and extending the duodenal wall for longer periods. Gel immersion is also effective during EUS-TA for pancreatic head cancer via the duodenal bulb ([Fig. 2]), EUS-guided gallbladder drainage (EUS-GBD) ([Fig. 3]), and the EUS-guided rendezvous technique for challenging transpapillary biliary cannulation ([Fig. 4]). This enhances both the visualization and the safety of punctures. Endoscopy_UCTN_Code_TTT_1AS_2AD Article published online: 30 July 2024 Ā© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Open Access

    Enhancing visibility and hemostasis during necrosectomy for walled-off necrosis: the ā€œdual-gel methodā€

    byĀ Kazuki Hama, Haruka Toyonaga, Tatsuya Ishii, Masayo Motoya, Toshifumi Kin, Tsuyoshi Hayashi, Akio Katanuma

    Endoscopic necrosectomy is an effective treatment for walled-off necrosis (WON); however, bleeding complications can be life threatening and require an immediate response [1]. Blood accumulation within the WON compartment makes identifying bleeding blood vessels difficult. Furthermore, the use of clips for hemostasis increases the risk of leaving long-term remains within the WON. Recently, a method for maintaining visibility during gastrointestinal bleeding involving the injection of a gel with an appropriate viscosity (Viscoclear; Otsuka Pharmaceutical Factory, Inc., Tokushima, Japan) was reported [2] [3]. Additionally, the hemostatic effect of a self-assembling peptide gel (PuraStat; 3-D Matrix Europe SAS, Lyon, France) used during gastrointestinal endoscopic procedures has been reported [4] [5]. Purastat is an aqueous peptide solution that becomes neutral upon contact with blood and body fluids, and its peptide molecules form fibers in solution to form a peptide hydrogel. This hydrogel quickly coats the bleeding point and stops the bleeding. In this case, we successfully employed a novel ā€œdual-gel methodā€ that uses Viscoclear and PuraStat to achieve hemostasis during endoscopic necrosectomy. A 58-year-old man presented with significant exudative bleeding during endoscopic necrosectomy. The bleeding continued unabated, and the exact location of the bleeding point was unclear because blood had pooled within the WON ([Fig. 1]). An auxiliary injection cap (BioShield irrigator; US Endoscopy, Mentor, Ohio, USA) was used to free the channel, and Viscoclear was injected via an injection cap ([Fig. 2]). The injection of Viscoclear facilitated the separation of blood and gel, thereby enabling identification of the bleeding point ([Fig. 3]). Subsequently, PuraStat injections resulted in effective hemostasis ([Fig. 4]). The gel-forming properties of PuraStat repaired the injured vessel wall, ensured stability, and sustained its hemostatic effect ([Fig. 5]). The ā€œdual-gel methodā€ is a useful hemostatic technique for managing exudative bleeding within confined spaces of WON ([Video 1]). Endoscopy_UCTN_Code_TTT_1AS_2AJ Article published online: 08 July 2024 Ā© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Novel grasp-and-snare technique for efficient endoscopic necrosectomy of walled-off necrosis

    byĀ Haruka Toyonaga, Tsuyoshi Hayashi, Kazuki Hama, Toshifumi Kin, Masayo Motoya, Kuniyuki Takahashi, Akio Katanuma

    Walled-off necrosis (WON) is a significant local complication of severe pancreatitis. Despite the utilization of endoscopic ultrasound-guided drainage, if necrotic debris accumulates within the WON and infection remains uncontrolled, direct endoscopic necrosectomy (DEN) is performed using auxiliary instruments such as forceps or snares [1] [2]. Conventional techniques often involve prolonged and multiple sessions because of their limited ability to remove necrotic material, leading to a substantial patient burden. Here we present an efficient adaptation of the two-channel method [3], commonly utilized for endoscopic mucosal resection ([Fig. 1]), for DEN, termed the ā€œgrasp-and-snareā€ technique. The procedure involves the use of a dual-channel endoscope (GIF-2TQ260M; Olympus, Tokyo, Japan), with one channel used to insert forceps for grasping and pulling lesions toward the operator and the other channel used to insert a snare for resecting the lesions. This technique enables simultaneous traction and snaring, rendering DEN safe and efficient ([Fig. 2], [Video 1]). A 47-year-old woman presented with a massive WON on computed tomography following severe gallstone pancreatitis ([Fig. 3]), for which conventional DEN proved inadequate for the removal of substantial necrotic material. Prior imaging confirmed the absence of blood flow within the necrotic cavity, endorsing the safety of invasive necrosectomy. The grasp-and-snare technique involved grasping and pulling the necrotic tissue using forceps operated through one channel of the endoscope, followed by precise snaring and removal of the extracted tissue via the other channel ([Fig. 4]). Any necrotic tissue resistant to tearing could be safely cut using high frequency electrical current (endoCUT Q mode, effect 2.0, VIO3; Erbe Elektromedizin, Tübingen, Germany). The grasp-and-snare technique can be used to safely remove a larger volume of necrotic debris in fewer attempts, potentially reducing the overall treatment time and patient burden. Endoscopy_UCTN_Code_TTT_1AS_2AJ Article published online: 07 June 2024 Ā© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Open Access

    Efficacy of a novel drill dilator in overcoming severe biliary strictures with balloon enteroscopy

    byĀ Haruka Toyonaga, Tsuyoshi Hayashi, Masayo Motoya, Toshifumi Kin, Kuniyuki Takahashi, Akio Katanuma

    In patients with altered anatomy, biliary strictures are widely overcome using balloon enteroscopy-assisted endoscopic retrograde cholangiopancreatography (BE-ERCP). As the balloon enteroscope has a small-diameter channel and scope maneuverability is poor, severe biliary strictures are often difficult to overcome. In such cases, dilation has previously been achieved using screw-type stent retrievers [1] [2]. Recently, however, a novel drill dilator (Tornus ES; Asahi Intecc Co., Ltd., Aichi, Japan) has been developed specifically for penetrating and dilating strictures [3] [4] [5]. Case 1: A woman aged in her 60s, with liver metastasis after subtotal stomach-preserving pancreaticoduodenectomy (SSPPD) for pancreatic head cancer presented with cholangitis due to a severe malignant stricture in the left hepatic bile duct ([Fig. 1]). Attempts to place a plastic stent using a balloon enteroscope (SIF-H290S, Olympus Co., Tokyo, Japan) were challenging because of the extreme hardness of the stricture. Despite trying another dilator, only a catheter was able to pass through. The novel drill dilator easily traversed and dilated the stricture, allowing for successful stent placement ([Fig. 2], [Video 1]). Case 2: A man aged in his 70s experienced cholangitis with intrahepatic biliary obstruction due to recurrence of distal bile duct cancer after SSPPD. It was determined that the obstruction in the posterior branch, where stenting had not been successful, was the main cause of cholangitis. The stricture was very tight and significantly angulated, making it impossible to traverse with any devices under BE-ERCP ([Fig. 3]). The rotational force and adequate flexibility of the novel drill dilator enabled the stricture to be successfully traversed and dilated, followed by successful stent placement ([Fig. 4], [Video 1]). In BE-ERCP, where the range of usable devices and maneuverability are limited, the novel drill dilator proved to be useful in dilating severe biliary strictures, even in patients with altered anatomy. Endoscopy_UCTN_Code_TTT_1AR_2AG Article published online: 08 March 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany


  • Tip‐in endoscopic papillectomy for ampullary adenoma near diverticulum to minimize complications

    byĀ Haruka Toyonaga, Tsuyoshi Hayashi, Kazuki Hama, Kosuke Iwano, Ryo Ando, Tatsuya Ishii, Toshifumi Kin, Masayo Motoya, Kuniyuki Takahashi, Akio Katanuma

  • Risk factors for early and late cholecystitis after covered metal stent placement for distal biliary obstruction

    byĀ Tatsuya Ishii, Tsuyoshi Hayashi, Hajime Yamazaki, Risa Nakamura, Kosuke Iwano, Ryo Ando, Haruka Toyonaga, Toshifumi Kin, Kuniyuki Takahashi, Akio Katanuma

    Background: Cholecystitis is a major adverse event after self‐expandable metallic stent placement for distal biliary obstruction (DBO). Covered self‐expandable metallic stent (CSEMS) is being increasingly used, but few studies have investigated risk factors for cholecystitis limited to CSEMS. The present study aimed to identify risk factors for cholecystitis after CSEMS.Methods: Patients who underwent initial CSEMS placement for DBO between November 2014 and September 2021 were enrolled and followed‐up until death, recurrent biliary obstruction, cholecystitis, or until March 2022. Cholecystitis within 30 days of CSEMS was defined as early cholecystitis and after 30 days as late cholecystitis.Results: Cholecystitis occurred in 51 of 339 patients (15%) after CSEMS. Forty‐one patients (80.4%) had early cholecystitis, and 10 (19.6%) had late cholecystitis. Multivariate logistic regression analysis revealed that the maximum diameter of the common bile duct (CBD) (per 1 mm increase) (odds ratio [OR]: 0.87; 95% confidence interval [CI]: 0.76–1.00; p = .044), gallbladder stones (OR: 3.63; 95% CI: 1.62–8.10; p = .002), and tumor involvement in the cystic duct (CD) (OR: 4.87; 95% CI: 2.16–11.00; p < .001) were significant independent risk factors associated with early cholecystitis. No significant risk factors were identified for late cholecystitis.Conclusions: A smaller CBD diameter, gallbladder stones, and tumor involvement in the CD were identified as risk factors for early cholecystitis development after CSEMS.


  • The application of low echo reduction in endoscopic ultrasound‐guided tissue acquisition for pancreatic mass lesions

    byĀ Haruka Toyonaga, Tsuyoshi Hayashi, Kazuki Hama, Kosuke Iwano, Ryo Ando, Tatsuya Ishii, Toshifumi Kin, Masayo Motoya, Kuniyuki Takahashi, Akio Katanuma

    Toyonaga and colleagues demonstrate, with accompanying video, the use of low echo reduction, which is a novel endoscopic ultrasound function provided by a new endoscopic ultrasound processor that increases contrast without white-out. Low echo reduction might be useful in improving lesion boundaries and needle visibility during endoscopic ultrasound-guided tissue acquisition.